News
Roche trial offers hope to patients with rare kidney disease
A study of Roche's Gazyva has raised the prospect of a first approved therapy for the rare kidney disorder primary membranous nephropathy.
News
AI in drug development news round-up
Recent developments in biopharma AI include an alliance between Thermo and Datavant, plus news from Insilico, Evinova, BPGbio, Evogene, and AMPLY.
R&D
The role of the opioid pathway in schizophrenia and bipolar ...
Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.
R&D
Sponsored
Advancing RSV and hMPV research through human challenge tria...
Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.
News
Bankruptcy threat looms as Quince runs out of options
Investor panic has poleaxed Quince Therapeutics share price, after a regulatory filing revealed the biotech's cash is running out.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
